March 30, 2015 9:28 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top stocks in the healthcare sector on the NASDAQ in terms of EPS growth forecast for the next five years.
Calithera Biosciences, Inc. (NASDAQ: CALA) earnings per share growth forecast for the next five years is 75.00%. Calithera Biosciences' trailing-twelve-month EPS is -$1.19.
Amedisys Inc. (NASDAQ: AMED) EPS growth forecast for the next five years is 74.55%. Amedisys' trailing-twelve-month revenue is $1.20 billion.
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) EPS growth forecast for the next five years is 70.00%. Sagent Pharmaceuticals' trailing-twelve-month revenue is $289.00 million.
Vital Therapies, Inc. (NASDAQ: VTL) earnings per share growth forecast for the next five years is 65.50%. Vital Therapies' trailing-twelve-month EPS is -$2.74.
Corcept Therapeutics Incorporated (NASDAQ: CORT) earnings per share growth forecast for the next five years is 49.30%. Corcept Therapeutics' trailing-twelve-month revenue is $26.60 million.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.